Morgan Stanley (MS) EBITDA Margin (2009 - 2026)

Morgan Stanley has disclosed EBITDA Margin across 18 years of filings, most recently posting 95.15% for Q1 2026.

• In Q1 2026, EBITDA Margin fell 34.0% year-over-year to 95.15%; the TTM figure through Mar 2026 stood at 100.17% (down 9.0% YoY), while the FY2025 annual figure was 100.46%, down 174.0% from the prior year.
• EBITDA Margin declined to 95.15% in Q1 2026, from 99.83% in the prior quarter.
• Over the last five years, EBITDA Margin for MS reached as high as 105.38% in Q3 2024 and fell as low as 33.93% in Q1 2022.
• The 5-year median for EBITDA Margin is 97.67% (2024), against an average of 86.59%.
• Annual changes were most pronounced in 2023 — EBITDA Margin jumped 5165 bps — and 2025, when it slumped 711 bps.
• A 5-year view of EBITDA Margin shows it stood at 76.14% in 2022, then surged by 33 bps to 101.03% in 2023, then declined by 3 bps to 97.67% in 2024, then advanced by 2 bps to 99.83% in 2025, then dropped by 5 bps to 95.15% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 95.15%, 99.83%, and 104.22% for Q1 2026, Q4 2025, and Q3 2025 respectively.